Medical Devices Malaysia

Malaysia Tuberculosis Diagnostics Market Analysis, 2024–2034

Malaysia Tuberculosis Diagnostics Market Industry Trends and Forecast to 2034: Segmented by (Test, Setting, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Malaysia · 2024–2034 · estimates

Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $4.2 Mn Estimated value
Estimate 2025 $4.5 Mn 0.2% of the global market
Projected 2034 $7.7 Mn 70.4% Adds $3.2 Mn over 9 forecast years
CAGR 2025–2034 6.1% Faster than 12% of 173 Medical Devices markets here
Key players 5
  • Malaysia is 0.17% of the global market.
  • In APAC, the largest is China at $232.9 Mn.
  • Fastest growing: India at 9.1% a year.
  • Malaysia ranks 8th of 10 by size in APAC.

Market size projection

Malaysia

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$3.2 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Tuberculosis Diagnostics Market market size by year, Malaysia
YearMarket sizeChange that yearSince 2025
2024 (estimate) $4.2 Mn — —
2025 (base) $4.5 Mn +$0.3 Mn —
2026 (forecast) $4.8 Mn +$0.3 Mn +6.1%
2027 (forecast) $5.1 Mn +$0.3 Mn +12.6%
2028 (forecast) $5.4 Mn +$0.3 Mn +19.4%
2029 (forecast) $5.7 Mn +$0.3 Mn +26.7%
2030 (forecast) $6.1 Mn +$0.3 Mn +34.5%
2031 (forecast) $6.4 Mn +$0.4 Mn +42.7%
2032 (forecast) $6.8 Mn +$0.4 Mn +51.4%
2033 (forecast) $7.2 Mn +$0.4 Mn +60.6%
2034 (forecast) $7.7 Mn +$0.4 Mn +70.4%

Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $2.58 Bn
  2. North America $1.30 Bn
  3. US $1.11 Bn
  4. APAC $618.7 Mn
  5. Europe $516.7 Mn
  6. China $232.9 Mn
  7. Canada $196.5 Mn
  8. Japan $179.7 Mn
  9. Latin America $128.5 Mn
  10. Middle East $118.2 Mn
  11. Germany $101.1 Mn
  12. France $75.2 Mn
  13. UK $58.7 Mn
  14. Italy $58.0 Mn
  15. Ecuador $59.1 Mn
  16. Spain $54.7 Mn
  17. Brazil $56.5 Mn
  18. India $52.5 Mn
  19. Saudi Arabia $42.9 Mn
  20. Africa $41.8 Mn
  21. Mexico $40.4 Mn
  22. Australia $35.3 Mn
  23. Russia $28.8 Mn
  24. New Zealand $28.4 Mn
  25. South Africa $18.5 Mn
  26. UAE $11.9 Mn
  27. Egypt $8.3 Mn
  28. Philippines $6.0 Mn
  29. Hong Kong $4.8 Mn
  30. Malaysia (this report) $4.5 Mn
  31. Singapore $2.8 Mn
  32. Thailand $2.8 Mn
  33. Kenya $1.6 Mn

The Malaysia Tuberculosis Diagnostics Market Analysis Executive Summary

Tuberculosis diagnostics find TB infection and disease using skin tests, blood tests, molecular tests and chest X-ray reading.

Key segments of the tuberculosis Diagnostics market include test (Molecular Tests, Interferon Gamma Release Assays and Skin Tests) and setting (Hospitals, TB Programs and Point of Care).

Malaysia Tuberculosis Diagnostics Market Dynamics

Market Growth Drivers

Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the tuberculosis Diagnostics market.

Opportunity

Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the tuberculosis Diagnostics market room to grow, especially in emerging markets.

Market Restraints

Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the tuberculosis Diagnostics market.

Competitive Landscape for Tuberculosis Diagnostics Market in Malaysia

The tuberculosis Diagnostics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Tuberculosis Diagnostics Market in Malaysia

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how tuberculosis Diagnostics products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Malaysia.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Tuberculosis Diagnostics right now, from free public sources.

Clinical trials

3 active trials in Malaysia

Recruiting, about to start, or running now.

Top trial sponsors (worldwide)

  1. PT Bio Farma 2 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 2 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Shanghai Jiatan Pharmatech Co., Ltd 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Latest research 80 papers since 2021 (worldwide)

  1. Next-Generation Mycobacterium tuberculosis Diagnostics: A Systematic Review of Molecular, CRISPR, and Biosensor Technologies. Recent patents on biotechnology, 2026
  2. [Skin changes - trivial or an indication of a more serious underlying disease?]. Praxis, 2026
  3. Programmable Multisite Recognition Enables Amplification-Free Nanopore Detection of Mycobacterium tuberculosis in Sputum and Plasma. Nano letters, 2026
  4. Bridging healthcare gaps through public-private partnerships in Nigeria: a scoping review. International health, 2026
  5. Over-expression, purification, and characterisation of Mycobacterium tuberculosis MPT64 from inclusion bodies. Protein expression and purification, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Tuberculosis Diagnostics in context

Malaysia compared

  • Health spending per person: 450 US$ per person (2023). World: 1,317 US$ per person (2023). 6th highest of the 15 countries we cover in APAC.[1]
  • Doctors: 2.34 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). 6th highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 8.0% of people (2025). World: 10.4% of people (2025). 8th highest of the 16 countries we cover in APAC.[3]

Questions, answered with public data

How many clinical trials on Tuberculosis Diagnostics are running in Malaysia?
3 studies are recruiting, active or about to start in Malaysia.[4]
How much research is published on Tuberculosis Diagnostics?
PubMed lists 80 papers added since January 2021 that match this market, worldwide.[5]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 13 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 13 Nov 2026.

[4] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Malaysia. Retrieved 12 Nov 2026.

[5] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.

Free data on this topic

Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Tuberculosis Diagnostics in Malaysia? Our analysts can size it for your plan. Talk to us See the public data Tuberculosis new cases for every country, free. Open the Public Health Dashboard

From our blog

Dermatology Diagnostics: AI and Skin HealthSkin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions… Molecular Point-of-Care Tests: Lab Accuracy, Clinic SpeedTB killed 1.23 million people in 2024. WHO now recommends rapid molecular tests first, bringing lab-grade… Healthcare In-Vitro Diagnostics: What Comes After COVIDCOVID-19 testing created a huge, short-lived spike. Long-term demand for in-vitro diagnostics now comes from…
Back to Catalogue
Keep exploring

Related Medical Devices reports in Malaysia

See all
Same topic, other categories

Related on diagnostics and lab testing and tuberculosis

See the topic